黑料网

Hemoglobin; Hematocrit; Erythropoiesis

Introduction

Early detection and management are crucial to prevent long-term complications, which can include growth retardation and neurodevelopmental delays. Diagnosis typically involves a complete blood count (CBC) to assess hemoglobin levels, reticulocyte count, and the examination of blood smears. Further diagnostic workup may include Coombs test, evaluation for blood group incompatibility, and screening for congenital infections or genetic disorders. Treatment depends on the underlying cause and severity of anemia. Mild cases may require no treatment other than monitoring, while more severe cases may necessitate blood transfusions, treatment of the underlying cause (e.g., phototherapy for hemolytic disease), and in some instances, administration of erythropoiesis-stimulating agents.

Discussion

Recent advances in neonatal care have improved the outcomes for infants with neonatal anemia, though the condition remains a significant cause of morbidity and mortality in this population. Ongoing research focuses on refining diagnostic techniques, optimizing transfusion practices, and exploring new therapeutic strategies to better manage neonatal anemia and its complications. Neonatal anemia is based on several interconnected physiological and pathological theories that explain its occurrence, progression, and impact on newborns. These theories encompass the physiological adaptations of newborns, the pathological mechanisms involved, and the implications of anemia on infant health. Fetal to Neonatal Transition: The transition from fetal to extrauterine life involves significant physiological changes, including a shift from fetal hemoglobin (HbF) to adult hemoglobin (HbA). This transition can initially lead to a natural decrease in hemoglobin levels, known as physiological anemia of the newborn. Typically, this decline is mild and self-limiting, resolving as the newborn's erythropoietic system matures During fetal life, the high levels of HbF are well-suited to the lower oxygen environment of the uterus. After birth, the increased oxygen availability prompts a natural decline in HbF and a rise in HbA. This physiological adaptation can lead to a temporary drop in hemoglobin levels, which is usually compensated by the infant's evolving erythropoietic capacity. Neonatal anemia can result from acute or chronic blood loss. Acute blood loss, such as from birth trauma, placental abruption, or iatrogenic causes, can lead to immediate anemia. Chronic blood loss may occur in conditions like twin-to-twin transfusion syndrome or gastrointestinal bleeding, leading to gradual anemia. Hemolysis, or the premature destruction of red blood cells, can cause neonatal anemia. [1-4].

These conditions interfere with the production and maturation of red blood cells, contributing to anemia. Impact on Oxygen Delivery: Anemia impairs the blood’s ability to carry oxygen to tissues, which can lead to clinical manifestations such as poor feeding, lethargy, and in severe cases, heart failure or shock. The severity of anemia directly influences the clinical outcome and requires timely intervention. Chronic or severe neonatal anemia has been associated with potential long-term consequences, including developmental delays, cognitive impairments, and growth retardation. The theory posits that adequate oxygenation is critical for normal brain development and overall growth during the neonatal period. The theory behind effective management emphasizes the importance of early detection and appropriate treatment to mitigate the risks associated with neonatal anemia. This includes monitoring hemoglobin levels, identifying the underlying cause, and providing targeted interventions such as blood transfusions or treatment for the underlying condition. Strategies to prevent neonatal anemia include adequate prenatal care to manage risk factors, such as blood group incompatibilities and maternal nutritional status. Prenatal screening and prophylactic measures, such as the administration of Rh immunoglobulin, play a role in reducing the incidence of hemolytic anemia. In summary, the theory of neonatal anemia integrates the physiological transition of newborns, the pathological mechanisms causing anemia, and the clinical implications for infant health [5-8].

The most common presentation of NAH is an asymptomatic palpable flank mass which resolves over time without intervention. In rare cases, NAH can present as hemorrhage, shock, or adrenal insufficiency. This case describes a preterm infant born with severe anemia in the setting of bilateral adrenal hemorrhages with resulting adrenal insufficiency. The infant was successfully treated with blood transfusions and steroids. This is a unique presentation of NAH as it was bilateral, presented with severe anemia, and resulted in prolonged adrenal insufficiency. A fetus with features of hydrops was given intra-uterine transfusion at 27 weeks and 31 weeks of gestation. Mother had been alloimmunized with anti-D and anti-C antibodies. At birth, laboratory investigations revealed bone marrow suppression along with features of hemolytic anemia. The neonate was started on a combination of phototherapy and intravenous immunoglobulin. During the course, the neonate was transfused with one unit of packed red cells (top-up transfusion). Neonatal hyperbilirubinemia responded to phototherapy and the bone marrow activity spontaneously resumed after 3 weeks of life. In neonates with anemia at birth who have history of multiple intra-uterine transfusions, early-onset hypoproliferative anemia should be considered. The development of anemia after birth in very premature, critically ill newborn infants is a universal well-described phenomenon. Although preventing anemia in this population, along with efforts to establish optimal red blood cell (RBC) transfusion and pharmacologic therapy continue to be actively investigated, the present review focuses exclusively on nonpharmacological approaches to the prevention and treatment of neonatal anemia. We begin with an overview of topics relevant to nonpharmacological techniques. These topics include neonatal and fetoplacental hemoglobin levels and blood volumes.

Conclusion

They include increasing hemoglobin endowment and circulating blood volume at birth; removing less blood for laboratory testing; and optimizing nutrition. Neonatal anemia and the need for red blood cell (RBC) transfusions are very common in neonatal intensive care units. Neonatal anemia can be due to blood loss, decreased RBC production, or increased destruction of erythrocytes. Physiologic anemia of the newborn and anemia of prematurity are the two most common causes of anemia in neonates. Phlebotomy losses result in much of the anemia seen in extremely low birthweight infants (ELBW). Accepting a lower threshold level for transfusion in ELBW infants can prevent these infants being exposed to multiple donors.

References

1. Hussain, Walid A, Jeremy D (2019)Neo Reviews 20: 213–221.

, ,

2. Bordessoule, Alice (2012). Pedia Res 72: 194–202.

, ,

3. Chiew, Yeong Shiong (2013). BioMedi Eng 12: 456-564.

, ,

4. Sonune VG, Bhagile JB (2021) IJRAMT 2: 215-217.

, ,

5. Joice SM, Tricia SF, Raquel CGL, Veronica CV, Danielle SDM (2021). Rev Assoc Med Bras 67: 150-155.

, ,

6. Wen LL, Chang WH, Wang HW (2021). J Obstet Gyne 60: 805-806.

, ,

7. Goligher, Ewan C (2012). Anesthesio 117: 463–464.

, ,

8. Stein H (2013). Am J Perinatol 33:707–711.

, ,